Literature DB >> 6424236

Methotrexate osteopathy.

A M Schwartz, J C Leonidas.   

Abstract

Methotrexate osteopathy is an uncommon complication of long-term oral maintenance therapy for childhood neoplasms, most commonly acute lymphocytic leukemia. It is characterized by severe lower extremity pain and by osteoporosis particularly involving the lower extremities and thick dense provisional zones of calcification and growth arrest lines resembling scurvy. Fractures may occur. The appearance must be distinguished from recurrent or metastatic disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6424236     DOI: 10.1007/bf00361126

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  5 in total

1.  Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems.

Authors:  M Nesbit; W Krivit; R Heyn; H Sharp
Journal:  Cancer       Date:  1976-02       Impact factor: 6.860

2.  Fractures in children treated with methotrexate for leukemia.

Authors:  S Stanisavljevic; A L Babcock
Journal:  Clin Orthop Relat Res       Date:  1977-06       Impact factor: 4.176

3.  Methotrexate-induced bone pain in childhood leukemia.

Authors:  S O'Regan; D K Melhorn; A J Newman
Journal:  Am J Dis Child       Date:  1973-10

4.  Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission.

Authors:  A H Ragab; R S Frech; T J Vietti
Journal:  Cancer       Date:  1970-03       Impact factor: 6.860

5.  Stress fracture in soldiers: a multifocal bone disorder. A comparative radiological and scintigraphic study.

Authors:  K O Meurman; S Elfving
Journal:  Radiology       Date:  1980-02       Impact factor: 11.105

  5 in total
  21 in total

Review 1.  Topics in pediatric leukemia--acute lymphoblastic leukemia and late effects in long-term survivors.

Authors:  Jacqueline Casillas; Kathleen M Sakamoto
Journal:  MedGenMed       Date:  2005-03-07

Review 2.  Magnetic resonance imaging of bone marrow in oncology, Part 2.

Authors:  Sinchun Hwang; David M Panicek
Journal:  Skeletal Radiol       Date:  2007-05-11       Impact factor: 2.199

3.  Tibial stress fracture mimicking neuroblastoma metastasis in two young children.

Authors:  M J Tuite; A A De Smet; P S Gaynon
Journal:  Skeletal Radiol       Date:  1995-05       Impact factor: 2.199

Review 4.  Medication-induced osteoporosis: screening and treatment strategies.

Authors:  Keshav Panday; Amitha Gona; Mary Beth Humphrey
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-10       Impact factor: 5.346

5.  Growth Arrest Line Mimicking Lymphoma Involvement: The Findings of (99m)Tc-MDP Bone SPECT/CT and Serial Bone Scan in a Child with Non-Hodgkin's Lymphoma.

Authors:  Chanwoo Kim; Ji Young Kim; Yun Young Choi; Seunghun Lee; Young-Ho Lee
Journal:  Nucl Med Mol Imaging       Date:  2016-01-27

Review 6.  Osteonecrosis in children with acute lymphoblastic leukemia.

Authors:  Marina Kunstreich; Sebastian Kummer; Hans-Juergen Laws; Arndt Borkhardt; Michaela Kuhlen
Journal:  Haematologica       Date:  2016-10-14       Impact factor: 9.941

7.  Risk factors for vertebral fracture in menopausal or postmenopausal Japanese women with rheumatoid arthritis: a cross-sectional and longitudinal study.

Authors:  Katsumitsu Arai; Tadamasa Hanyu; Hiroya Sugitani; Takehiro Murai; Junichi Fujisawa; Kiyoshi Nakazono; Naoki Kondo; Naoto Endo
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

8.  Methotrexate osteopathy in rheumatic disease.

Authors:  S J Preston; T Diamond; A Scott; M R Laurent
Journal:  Ann Rheum Dis       Date:  1993-08       Impact factor: 19.103

9.  The effect of low-dose methotrexate on bone mineral density in patients with early rheumatoid arthritis.

Authors:  Funda Tascioglu; Cengiz Oner; Onur Armagan
Journal:  Rheumatol Int       Date:  2003-03-21       Impact factor: 2.631

10.  Metaphyseal growth arrest lines in psychosocial short stature.

Authors:  V V Khadilkar; F L Frazer; D H Skuse; R Stanhope
Journal:  Arch Dis Child       Date:  1998-09       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.